Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Biofrontera Inc maintains a gross margin of 70.74%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -89.84%, while the net margin is -95.15%. These profitability ratios, combined with a Return on Equity (ROE) of -1191.73%, provide a clear picture of how effectively BFRI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BFRI competes directly with industry leaders such as APRE and PULM. With a market capitalization of $10.76M, it holds a leading position in the sector. When comparing efficiency, BFRI's gross margin of 70.74% stands against APRE's 100.00% and PULM's N/A. Such benchmarking helps identify whether Biofrontera Inc is trading at a premium or discount relative to its financial performance.
